Cytonus Therapeutics
Signal active
Organization
Contact Information
Overview
Cytonus Therapeutics is a biotech company combining AI-driven drug discovery with a Cargocyte, a synthetic biology approach towards drug-delivery. Cytonus is on a mission to treat immune related disorders with precision delivery and in vivo production of first in class therapeutics.
About
Industries
Biotechnology, Health Care, Medical
Founded
2018
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cytonus Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $3.0B in funding across 144 round(s). With a team of 11-50 employees, Cytonus Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Cytonus Therapeutics, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
12
Investors
0
Lead Investors
0
Total Funding Amount
$20.9M
Details
3
Cytonus Therapeutics has raised a total of $20.9M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | |||
| 2022 | Seed | 1.8M | ||
| 2023 | Early Stage Venture | 11.7M |
Investors
Cytonus Therapeutics is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Prox Ventures | - | FUNDING ROUND - Prox Ventures | 11.7M |
| Wilson Sonsini Goodrich & Rosati | - | FUNDING ROUND - Wilson Sonsini Goodrich & Rosati | 11.7M |
| Cytonus Therapeutics | - | FUNDING ROUND - Cytonus Therapeutics | 11.7M |
| Creative Ventures | - | FUNDING ROUND - Creative Ventures | 11.7M |
Recent Activity
There is no recent news or activity for this profile.